Eyal Grunebaum

Read how they describe their research on their University of Toronto profile.

• Peanut Oral Immunotherapy Using 30 and 300 mg Maintenance Doses.

  The journal of allergy and clinical immunology. In practice · 2026

• Gene alterations in inborn errors of immunity and their presence in cancers: Implications for oncogenesis, progression, and outcomes.

  Human immunology · 2026

• Redefining Expertise: Preparing the Next Generation of Physicians Caring for Patients with Inborn Errors of Immunity.

  The Israel Medical Association journal : IMAJ · 2026 · senior author

• Gene therapy for pediatric primary immune deficiency

  CIHR · 2021 · Supervisor

  $6,000

• Carrier-mediated delivery of therapeutic proteins into the brain

  BRAIN · 2014 · Co-investigator

  $1,662,500

• Primary EBV Infection in the Immunosuppressed Setting of Organ Transplantation: Determinants of the Outcomes of Virus-Host Interaction

  CIHR · 2009 · Co-investigator

  $509,125